Daejeon, South Korea

Hye Sung Lee

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hye Sung Lee: Innovator in Pharmaceutical Composition for Tremor Treatment

Introduction

Hye Sung Lee is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of tremors and tremor syndrome. His innovative approach has led to the development of a unique pharmaceutical composition that utilizes a specific carbamate compound.

Latest Patents

Hye Sung Lee holds 1 patent for his invention titled "Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndrome." This patent describes a pharmaceutical composition that includes a carbamate compound of chemical formula 1, which is administered to prevent, alleviate, or treat tremors or tremor syndrome. This invention showcases his commitment to addressing neurological disorders through innovative solutions.

Career Highlights

Hye Sung Lee is currently associated with Sk Biopharmaceuticals Co., Ltd., where he continues to work on groundbreaking pharmaceutical research. His role in the company allows him to collaborate with other talented professionals in the field, further enhancing the impact of his work.

Collaborations

Some of his notable coworkers include Jin Uk Yoo and Han Ju Yi. Their collaboration fosters a dynamic environment for innovation and research, contributing to the advancement of pharmaceutical solutions.

Conclusion

Hye Sung Lee's contributions to the field of pharmaceuticals, particularly in the treatment of tremors, highlight his innovative spirit and dedication to improving patient care. His work exemplifies the importance of research and collaboration in developing effective medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…